STAT+: Overton won’t get a vote before midterms
Health department nominees await Senate votes, and we map out what the elections mean for healthy policy.
The Senate health committee will vote on Wednesday whether to approve Heidi Overton for the FDA leadership position. However, she will not be among the three nominees for the Health and Human Services (HHS) nominees. Overton's nomination is uncertain as it would take just one Republican to oppose her in committee. The Senate's health committee has no scheduled vote on the FDA nominee until after the midterm elections on November 9.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
